CompletedPhase 2NCT01912053

Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Center Eugene Marquis
Principal Investigator
Eveline Boucher, MD, M.D
Centre Eugene Marquis
Intervention
Therasphere® in association with Gemcitabine and Cisplatin(radiation)
Enrollment
41 target
Eligibility
18 years · All sexes
Timeline
2013 – 2017

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01912053 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma →

← Back to all trials